Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 7
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Molecular modeling aided design, synthesis and biological evaluation of quinazoline derivatives for the treatment of human cancer
Cai‐Shi Liu, Jin-Peng Tong, Zheng Fang, et al.
Molecular Diversity (2025)
Closed Access
A bioactive polysaccharide derived from Rosa laevigata fruits: Structural properties, antitumor efficacy, and potential mechanisms
Xiaoyang Guo, Fan Nie, Haojing Jiang, et al.
International Journal of Biological Macromolecules (2025), pp. 140382-140382
Closed Access
Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma
Xiao Wang, Yin-Ru Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117328-117328
Closed Access
Clinical Importance of Focal Adhesion Kinase (FAK)-Src and Paxillin Expression in Renal Cell Carcinoma
Panagiotis Mitsos, Ioannis Anastasiou, Constantinos Constantinides, et al.
Cureus (2024)
Open Access | Times Cited: 1
Marein Alleviates Doxorubicin-Induced Cardiotoxicity through FAK/AKT Pathway Modulation while Potentiating its Anticancer Activity
Juanjuan Xu, Manjun Lv, Xiaohong Ni
Cardiovascular Toxicology (2024) Vol. 24, Iss. 8, pp. 818-835
Closed Access | Times Cited: 1
Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics
Lawrence W. Wu, Sung Joo Jang, Cameron Shapiro, et al.
Targeted Oncology (2024)
Open Access | Times Cited: 1
Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression
Louis Boafo Kwantwi, Theophilus Tandoh
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Grammatophyllum speciosum ethanolic extract inhibits proliferation and migration of non-small cell lung cancer cells through focal adhesion kinase/AKT/β-catenin-dependent pathway
Verisa Chowjarean, Saraporn Harikarnpakdee, Preeyaporn Plaimee Phiboonchaiyanan
Journal of Advanced Pharmaceutical Technology amp Research (2024) Vol. 15, Iss. 4, pp. 332-340
Open Access | Times Cited: 1
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
Yunmei Zhang, Shiyu Wei, Zhengjie Chen, et al.
Advanced Science (2024)
Open Access
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access
Mechano-assisted strategies to improve cancer chemotherapy
Shanshan Zhu, Guorui Jin, Xiaocong He, et al.
Life Sciences (2024), pp. 123178-123178
Closed Access
Identifying CEACAM1 as a potential prognostic biomarker for basal-like breast cancer by bioinformatics analysis and in vitro experiments
Boke Zhang, Ran Liu, Haixia Huang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 19, pp. 6468-6478
Open Access
Design, Synthesis, and Evaluation of Trihalomethyl Ketone Derivatives of Neocarzilin A as Improved Antimetastatic Agents
Noah M. Moriarty, Annaleigh Benton, Lauren E. Gartenhaus, et al.
ACS Bio & Med Chem Au (2024) Vol. 4, Iss. 6, pp. 331-341
Open Access
CCN2: a potential contributor to gingival overgrowth
A. A. Fadl, Andrew Leask
Journal of Oral Biosciences (2024), pp. 100587-100587
Open Access
The integrin adhesome and control of anti-tumour immunity
Emily R. Webb, Annabel Black, Nicole D. Barth, et al.
Biochemical Society Transactions (2024)
Closed Access
CSE1L in enhancing the effect of defactinib on gastric cancer cells via the inhibition of FAK phosphorylation
Xin He, Yating Wang, Yanning Zhang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 12, pp. 6905-6918
Open Access
Page 1

Scroll to top